Exomine® - Autologous Platelet-Derived Exosomes

Exomine® – Autologous exosomes from the patient's own blood

Exomine® Kit is an innovative, autologous system for producing plasma rich in platelet-derived exosomes. Since the treatment is based on the patient's own blood, the risk of side effects such as allergic reactions and immunological complications is minimized.

Using a unique protocol, platelets in PRP are activated, releasing billions of biologically active vesicles (exosomes). The result is a concentrated plasma that can be used for advanced regenerative treatments.

Benefits

• Autologous treatment – high safety
• No risk of allergic reactions
• High concentration of exosomes
• Supports regenerative processes
• Simple and effective production protocol

How it works

The Exomine® kit activates platelets and selected blood cells in PRP, stimulating the release of exosomes. These microscopic signaling carriers play a central role in cell communication and tissue regeneration.

Application

Suitable for clinics working with regenerative treatments that require an advanced and biologically based approach.